These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29210332)

  • 1. Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.
    Randesi M; van den Brink W; Levran O; Yuferov V; Blanken P; van Ree JM; Ott J; Kreek MJ
    Pharmacogenomics; 2018 Jan; 19(2):95-104. PubMed ID: 29210332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VMAT2 gene (
    Randesi M; van den Brink W; Levran O; Blanken P; van Ree JM; Ott J; Kreek MJ
    Pharmacogenomics; 2019 Apr; 20(5):331-341. PubMed ID: 30983500
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine D1 receptor gene variation modulates opioid dependence risk by affecting transition to addiction.
    Zhu F; Yan CX; Wen YC; Wang J; Bi J; Zhao YL; Wei L; Gao CG; Jia W; Li SB
    PLoS One; 2013; 8(8):e70805. PubMed ID: 23976958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.
    Moran M; Blum K; Ponce JV; Lott L; Gondré-Lewis MC; Badgaiyan S; Brewer R; Downs BW; Fynman P; Weingarten A; Cadet JL; Smith DE; Baron D; Thanos PK; Modestino EJ; Badgaiyan RD; Elman I; Gold MS
    Mol Neurobiol; 2021 Jul; 58(7):3335-3346. PubMed ID: 33683627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of functional DBH genetic variants with alcohol dependence risk and related depression and suicide attempt phenotypes: results from a large multicenter association study.
    Preuss UW; Wurst FM; Ridinger M; Rujescu D; Fehr C; Koller G; Bondy B; Wodarz N; Soyka M; Zill P
    Drug Alcohol Depend; 2013 Dec; 133(2):459-67. PubMed ID: 23906995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
    Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
    J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Food addiction' and its association with a dopaminergic multilocus genetic profile.
    Davis C; Loxton NJ; Levitan RD; Kaplan AS; Carter JC; Kennedy JL
    Physiol Behav; 2013 Jun; 118():63-9. PubMed ID: 23680433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of SNPs in the dopamine-β-hydroxylase gene providing new insights into its structure-function relationship.
    Punchaichira TJ; Dey SK; Mukhopadhyay A; Kundu S; Thelma BK
    Neurogenetics; 2017 Jul; 18(3):155-168. PubMed ID: 28707163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational Studies of Sex Differences in Sensitivity to Opioid Addiction.
    Chartoff EH; McHugh RK
    Neuropsychopharmacology; 2016 Jan; 41(1):383-4. PubMed ID: 26657961
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.
    Kosten TR; Wu G; Huang W; Harding MJ; Hamon SC; Lappalainen J; Nielsen DA
    Biol Psychiatry; 2013 Feb; 73(3):219-24. PubMed ID: 22906516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common and specific liability to addiction: approaches to association studies of opioid addiction.
    Nielsen DA; Kreek MJ
    Drug Alcohol Depend; 2012 Jun; 123 Suppl 1(0 1):S33-41. PubMed ID: 22542464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium.
    Polimanti R; Walters RK; Johnson EC; McClintick JN; Adkins AE; Adkins DE; Bacanu SA; Bierut LJ; Bigdeli TB; Brown S; Bucholz KK; Copeland WE; Costello EJ; Degenhardt L; Farrer LA; Foroud TM; Fox L; Goate AM; Grucza R; Hack LM; Hancock DB; Hartz SM; Heath AC; Hewitt JK; Hopfer CJ; Johnson EO; Kendler KS; Kranzler HR; Krauter K; Lai D; Madden PAF; Martin NG; Maes HH; Nelson EC; Peterson RE; Porjesz B; Riley BP; Saccone N; Stallings M; Wall TL; Webb BT; Wetherill L; ; Edenberg HJ; Agrawal A; Gelernter J
    Mol Psychiatry; 2020 Aug; 25(8):1673-1687. PubMed ID: 32099098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson's disease.
    Cilia R; Benfante R; Asselta R; Marabini L; Cereda E; Siri C; Pezzoli G; Goldwurm S; Fornasari D
    Parkinsonism Relat Disord; 2016 Aug; 29():96-103. PubMed ID: 27237108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Vulnerability to Opioid Addiction.
    Reed B; Kreek MJ
    Cold Spring Harb Perspect Med; 2021 Jun; 11(6):. PubMed ID: 32205416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine Hydroxylase Gene Polymorphisms Contribute to Opioid Dependence and Addiction by Affecting Promoter Region Function.
    Liu JL; Li SQ; Zhu F; Zhang YX; Wu YN; Yang JS; Zhang B; Yan CX
    Neuromolecular Med; 2020 Sep; 22(3):391-400. PubMed ID: 32232669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors.
    López-Moreno JA; López-Jiménez A; Gorriti MA; de Fonseca FR
    Curr Drug Targets; 2010 Apr; 11(4):406-28. PubMed ID: 20196742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.
    Hess C; Reif A; Strobel A; Boreatti-Hümmer A; Heine M; Lesch KP; Jacob CP
    J Neural Transm (Vienna); 2009 Feb; 116(2):121-30. PubMed ID: 18982239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive association between--1021TT genotype of dopamine beta hydroxylase gene and progressive behavior of injection heroin users.
    Xie X; Xu L; Liu H; Chen W; Zhuang D; Zhang J; Duan S; Zhou W
    Neurosci Lett; 2013 Apr; 541():258-62. PubMed ID: 23510745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.
    Fang Y; Ji N; Cao Q; Su Y; Chen M; Wang Y; Yang L
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):625-32. PubMed ID: 26447643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.